Concepedia

Wakana Saso

WS

Statistics

Publications

13

Citations

885

H-Index

11

Active since

2018

Affiliations

National Institute of Infectious Diseases(Current)

The University of Tokyo

Tokyo University of Science

Kyoto University

Institut National de la Transfusion Sanguine

Wakana Saso is an author at National Institute of Infectious Diseases specializing in virology, molecular virology, and drug discovery.

Publications per year

2018–2022

13

Publications

13

Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization

Masashi Iwamoto, Wakana Saso, Ryuichi Sugiyama et al. · Proceedings of the National Academy of Sciences · 2019 · 241 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · iScience · 2021 · 181 citations · Full text

Veterinary Medicine, Infectious Diseases, Drug Discovery +6

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 83 citations

Medicine, Infectious Diseases, Pharmacology +17

De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry

Toby Passioura, Koichi Watashi, Kento Fukano et al. · Cell chemical biology · 2018 · 63 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network

Masashi Iwamoto, Wakana Saso, Kazane Nishioka et al. · Journal of Biological Chemistry · 2020 · 63 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–5 of 13